威高股份(01066.HK) 发盈喜，预计2024年度归属股东净利润介乎2亿至2.4亿人民币，较上年度增长78.1%-113.7%。年内，骨科耗材带量采购全面执行进入平稳期，公司积极执行带量采购政策，主动调整经营策略，重新规划产品线、优化成本控制、强化与医疗机构的合作关系，以及探索多元化市场渠道，最大限度提高市场份额和客户覆盖率，实现业绩增长。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-21 16:25。)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2024/08/28 | 中期业绩 | 股息：人民币 0.0919 (约相等于 0.1009 港元) |
| 2024/03/26 | 末期业绩 | 股息：人民币 0.0943 (约相等于 0.1035 港元) |
| 2023/08/29 | 中期业绩 | 股息：人民币 0.0734 (约相等于 0.08 港元) |
| 2023/03/30 | 末期业绩 | 股息：人民币 0.0790 (约相等于 0.087 港元) |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.